Abstract:In recent years, many nucleic acid-based pharmaceuticals have been approved and entered the market, and even a larger number are in late stage clinical trials. Conventional oligonucleotides are facing issues in vivo like fast renal clearance and nuclease degradation. Therefore, to increase their stability, phosphorothioation is a frequent modification of therapeutic oligonucleotides (ONs) which also leads to improved binding affinity facilitating cell internalization and intracellular distribution. At the same time, by replacing a phosphodiester linkage with a phosphorothioate group, a phosphorous stereogenic center is generated which causes the formation of Rp- and Sp-diastereomers. It increases the structural diversity. For example, with 15 of those phosphorothioate (PS) linkages, 32,768 different diastereomers are expected. Since the phosphorothioate is introduced non-stereoselectively, the molecular complexity of the resultant phosphorothioate ON products is tremendously increased impeding the chromatographic separation in the course of quality control. Since distinct phosphorothioate diastereomers have different bioactivities and pharmacological properties, there is increasing interest in implications of stereoisomerism of phosphorothiate oligonucleotides. From a quality and regulatory viewpoint, batch-to-batch reproducibility of the diastereomer profile may be of significant concern. In order to address this issue, this study investigates the stereoselectivity of LC methods for two phosphorothioate oligonucleotide (PSO) compounds differing in their molecular size and numbers of PS linkages. Diastereoselectivity of ion-pairing reversed-phase liquid chromatography (IP-RPLC), RPLC without ion-pairing agents and LC with chiral polysaccharide-based column were evaluated for model PSOs and an active pharmaceutical ingredient (API) of PSO with trivalent N-acetylgalactosamine (GalNAc) conjugate. Due to the structural complexity of PSOs, the separation power for the diastereomer mixture was increased by using sequential selective comprehensive two-dimensional chromatography with an amylose tris(α-methylbenzylcarbamate)-immobilized chiral stationary phase (CSP) in the first dimension and ion-pair RPLC with ethylammonium acetate in the second dimension. Improved diastereomer selectivity was obtained and a larger number of peaks could be separated.

Drug synthesis, separation, and identification of a di-stereoisomeric mixture of spiro-oxalidinonic derivatives of sorbinil by high-performance liquid chromatography

RP-HPLC Analysis of the Enantiomers of Esmolol and Its Metabolite in Human Blood with Solid-Phase Extraction

Analytical enantioseparation of N-alkyl drugs by reversed-phase liquid chromatography with carboxymethyl--cyclodextrin as mobile phase additive

Stereoselective Separation of Β-Adrenergic Blocking Agents Containing Two Chiral Centers by Countercurrent Chromatography.

Chemo-enzymatic Total Synthesis of Oxosorbicillinol, Sorrentanone, Rezishanones B and C, Sorbicatechol A, Bisvertinolone, and (+)-Epoxysorbicillinol

Simultaneous Determination of Diastereomers (+)-Licarin A and Isolicarin A from Myristica Fragrans in Rat Plasma by HPLC and Its Application to Their Pharmacokinetics.

Chemoenzymatic total synthesis of sorbicillactone A

Cu@SnS/SnO2 nanoparticles as novel sorbent for dispersive micro solid phase extraction of atorvastatin in human plasma and urine samples by high-performance liquid chromatography with UV detection: Application of central composite design (CCD)

Simultaneous Determination of Diastereoisomeric and Enantiomeric Impurities in SSS-octahydroindole-2-carboxylic Acid by Chiral High-Performance Liquid Chromatography with Pre-Column Derivatization

Two-dimensional sequential selective comprehensive chiral×reversed-phase liquid chromatography of synthetic phosphorothioate oligonucleotide diastereomers

Supercritical fluid chromatography based on reversed-phase/ ion chromatography mixed-mode stationary phase for separation of spiro oxindole alkaloids

Synthesis, X-ray diffraction analysis, quantum chemical studies and α-amylase inhibition of probenecid derived S-alkylphthalimide-oxadiazole-benzenesulfonamide hybrids

Simultaneous Determination of the Enantiomers of Esmolol and Its Acid Metabolite in Human Plasma by Reversed Phase Liquid Chromatography with Solid-Phase Extraction.

Direct Differentiation of Stereoisomers of Ezetimibe/ambrisentan/atorvastatin and Their Mechanism Study by Electrospray Ionization Quadrupole Time-of-flight Mass Spectrometry

Novel spirooxindole-triazole derivatives: unveiling [3+2] cycloaddition reactivity through molecular electron density theory and investigating their potential cytotoxicity against HepG2 and MDA-MB-231 cell lines

Chemoenzymatic Total Synthesis of Sorbicatechol Structural Analogues and Evaluation of Their Antiviral Potential

Enantioselective high-performance liquid chromatography of aryl-substituted oxazolines as an efficient tool for determination of chiral purity of serine medicinal components

One Pot Synthesis and Biological Activity Studies of New Spirooxindoles

Chemical Synthesis, Experimental, Molecular Docking and Drug-likeness Studies of Salidroside

P-Toluenesulfonyl Isocyanate As A Novel Derivatization Reagent to Enhance the Electrospray Ionization and Its Application in the Determination of Two Stereo Isomers of 3-Hydroxyl-7-methyl-norethynodrel in Plasma

QSRR Modeling of Lipophilicity of New Spirohydantoin Derivatives Determined with Various TLC Systems